about
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic ReviewBudesonide for induction of remission in Crohn's diseaseAcute hepatic failure and multi-system organ failure secondary to replacement of the liver with metastatic melanoma.Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel diseaseA comparison of outcomes between laparoscopic and open appendectomy in CanadaNon-specific abdominal pain and air pollution: a novel associationAir pollution effects on the gut microbiota: a link between exposure and inflammatory diseaseAmbient ozone and emergency department visits for cellulitisThe inflammatory bowel diseases and ambient air pollution: a novel associationEffect of ambient air pollution on the incidence of appendicitisAnti-tumor necrosis factor therapy and influenza: keeping it in perspective.Validation of coding algorithms for the identification of patients hospitalized for alcoholic hepatitis using administrative data.The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis.Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations.Heparin induced thrombocytopaenia secondary to intraperitoneal heparin exposure.Validity of administrative data for the diagnosis of primary sclerosing cholangitis: a population-based study.PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).Inflammatory bowel disease cause-specific mortality: a primer for cliniciansEnvironmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome.Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease.Upper gastrointestinal bleeding due to peptic ulcer disease is not associated with air pollution: a case-crossover studyClinical predictors of thiopurine-related adverse events in Crohn's disease.Fine particulate air pollution, nitrogen dioxide, and systemic autoimmune rheumatic disease in Calgary, AlbertaCharacterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing CholangitisThe risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and Denmark.Smoking Is Associated with an Increased Risk for Surgery in Diverticulitis: A Case Control StudyChallenges in designing a national surveillance program for inflammatory bowel disease in the United States.Incidence of Appendicitis over Time: A Comparative Analysis of an Administrative Healthcare Database and a Pathology-Proven Appendicitis Registry.Long-term outcomes of colectomy surgery among patients with ulcerative colitisQuantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individualsDepression in epilepsy: a systematic review and meta-analysisLaparoscopic versus open resection for colorectal cancer: a metaanalysis of oncologic outcomes.Microscopic colitis-defining incidence rates and risk factors: a population-based study.Survival after hepatic resection: impact of surgeon training on long-term outcomeAmbient ozone concentrations and the risk of perforated and nonperforated appendicitis: a multicity case-crossover study.Temporal trends in the use of diagnostic imaging for inpatients with pancreatic conditions: How much ionizing radiation are we using?The risk of developing Crohn's disease after an appendectomy: a meta-analysis.Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection.Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab.
P50
Q22250934-FE603104-BD81-428F-B6B0-EE614C1A553EQ24187309-379D0EF8-9C1D-44FD-82B1-5468107A6B32Q24816031-CB86F531-EB77-4C73-BA2B-091ABFE990D5Q26822029-8E956317-7910-4746-98BE-DE76E9EDEA11Q27005653-C9A73239-86ED-4D47-9902-FCBD903B6B23Q27313667-B5474697-0A06-48BE-9A70-C47496C49546Q28657873-89999EA9-4ED1-4BFB-815D-3CF96018E08EQ28744491-13B503E1-877A-4681-BA0C-BB482317EFECQ28744545-EF7C8532-9A7D-4EE5-BCC9-0FBFD48412F2Q28750460-08BEA876-61AC-4512-B9B6-FAFFF909046FQ30397819-E579D2C9-ADEF-46A3-9652-B8F24C071337Q30993162-08EC5B81-4644-475E-AB10-C805FCF47198Q31062385-DB265024-98F5-4755-82F8-1D2895754F7AQ31119855-85D2E3DA-D07A-48C6-B801-8D90AEA41E27Q33367245-7169D4D8-0D76-47E7-A8E1-838F76C10E76Q33860376-9D87F30D-1E43-4027-B0CA-833A3414C328Q34514665-08FB812B-3B07-48AE-8AF0-36ACBBF022B5Q34570452-4514660C-1C89-45E4-8E73-A9593B9F3AC8Q34701085-816150FB-D8F2-467D-88E0-E3EE71820E85Q35012116-A41E428E-6ACF-419C-BF7D-E9E417442C5AQ35155090-5819C9D4-A902-489F-8FD9-3080DE2717EBQ35807520-692B4A4F-1016-4698-A044-80DB86233A62Q35819552-5ADE036E-0232-473C-8200-42FA3FE2C17FQ35822686-1F3C1937-7A90-4E26-B733-B82E0562BB12Q35829727-96517EA4-C9D7-4B59-A72C-90AA44E0A418Q36023372-E28AA7B8-834F-4972-8394-B86E65F4E6B5Q36088359-A0826AB2-96DF-4D0B-80B1-0909DD2967A4Q36174814-3BFFF05F-39F2-4876-A39A-9EA9DD3571D4Q36184326-7CD00294-9086-4BDC-B59B-2B166442E532Q36234111-E1BA2522-13C1-4723-AFA4-B0C004BFCA14Q36570929-39E84B6E-7FD6-4951-B3AC-A21E74EBB525Q36659697-FB5C86EB-C660-4AB2-A9B3-A452C2D01048Q36745999-CFFB4FEF-FA7B-4229-BD1D-331644BD83DDQ37048042-92728F15-A3BA-47E3-86BE-9842FEDFF03AQ37057241-2CE35506-65B8-4576-8012-94FF6B2EC9C5Q37072605-EE5B1809-2952-407B-9CBF-28D0DBBF1A38Q37171126-0C98A105-C04E-405A-B976-E4881F8944C0Q37262193-70841424-BBDC-4E61-91B6-C571598D01F8Q37391438-09A9583D-9604-4C4D-BB6C-51A96F3B1321Q37579956-D8CD6D8B-DE3F-4CD7-A3B7-0E011A7BD4C1
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gilaad G. Kaplan
@ast
Gilaad G. Kaplan
@en
Gilaad G. Kaplan
@es
Gilaad G. Kaplan
@sl
type
label
Gilaad G. Kaplan
@ast
Gilaad G. Kaplan
@en
Gilaad G. Kaplan
@es
Gilaad G. Kaplan
@sl
prefLabel
Gilaad G. Kaplan
@ast
Gilaad G. Kaplan
@en
Gilaad G. Kaplan
@es
Gilaad G. Kaplan
@sl
P106
P1153
10042831100
P31
P496
0000-0003-2719-0556